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to face new challenges related to containing 
its rapid dissemination and delivering the 
appropriate treatment to the affected patients.
Although, to date, this disease has not proven 
to be more lethal than is seasonal influenza, it is 
a different disease, with different characteristics: 
it affects apparently healthy young individuals; 
transmission occurs very quickly; and its course 
can be severe.
It is the duty of epidemiological surveillance to 
keep case registries updated, especially regarding 
severe cases, and to identify potential risk factors 
for H1N1 infection.(2,3) Public and private health 
care facilities should be prepared to confront the 
situation, showing organizational capacity and 
allowing timely access to appropriate treatment. 
In addition, it is essential that an H1N1 vaccine 
be developed.
Introduction
The World Health Organization monitors 
diseases capable of spreading rapidly from one 
country to another, including infections that 
can result in severe acute respiratory syndrome 
(SARS).(1)
Among the principal etiologic agents 
that result in SARS are viruses (influenza A 
virus, dengue virus, respiratory syncytial virus, 
adenovirus, hantavirus and coronavirus) and 
other agents (pneumococci, other bacteria, 
Legionella sp., leptospirosis, etc.) The diagnosis 
of viral pneumonia is a differential diagnosis and 
is based on the absence of sputum production, 
failure to detect bacteria on culture and normal 
or slightly elevated leukocyte counts.(1)
The emergence of the flu pandemic caused 
by a new subtype of the influenza A virus (H1N1) 
has forced populations and health professionals 
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Doppler echocardiogram and X-ray of the 
paranasal sinuses were normal.
Blood and urine cultures were negative for 
aerobic and anaerobic microorganisms. Testing 
(real-time PCR) of oropharyngeal secretion aspirate 
was positive for the influenza A (H1N1) virus.
The patient was admitted to the ICU 
and treated with oseltamivir, ceftriaxone, 
azithromycin and a corticosteroid. He received 
ventilatory support with intermittent positive 
pressure breathing, which was maintained at 
50% via a Venturi mask, at a resting SpO2 of 
92%. The patient progressively improved and 
was discharged from the ICU ten days later, 
presenting an SpO2 of 94% on room air, together 
with radiological improvement (Figure 3). He 
developed no fever or hemodynamic instability 
during the hospital stay.
Discussion
According to the influenza surveillance 
protocol, cases of SARS are defined as those 
Case report
A 56-year-old nonsmoking businessman 
from São Paulo, Brazil, presented with mild 
hypertension controlled with candesartan 
(8 mg/day). The patient reported no diabetes or 
other comorbidities.
In the previous week, the patient had 
developed the flu, characterized by fever 
(38.5°C), generalized pain, rhinorrhea and 
nasal obstruction. Three days later, he began to 
present extreme fatigue and malaise and sought 
treatment in the emergency room, where he was 
submitted to chest X-ray and was diagnosed 
with pneumonia. On that same date, the blood 
workup revealed the following: hemoglobin, 
14.8 g/dL; hematocrit, 41.9%; leukocytes, 
4,600/mm3 (3-85-0-0-11-1); platelet count, 
132,000/mm3; and ESR, 16 mm/h. The patient 
was treated with oral moxifloxacin and was 
instructed to return if his condition worsened. 
Since the patient felt increasingly tired, he 
returned to the emergency room two days later. 
He reported no contact with suspected cases of 
infection with influenza A (H1N1) virus.
Physical examination revealed that the 
patient was in satisfactory general health, was 
well hydrated and with good color, had no 
jaundice or lymph node enlargement and had +/4 
cyanosis and +++/4 dyspnea. In addition, physical 
examination revealed the following: arterial 
pressure, 130-90 mmHg; body temperature, 
36.8°C; weight, 68 kg; height, 1.65 m; BMI, 
25.0 kg/m2; and RR, 30 breaths/min. Pulmonary 
auscultation revealed diffuse crackles in both 
lungs and normal, rhythmic heart sounds without 
heart murmurs. There were no organomegalies in 
his abdomen, there was no edema in his limbs, 
and his SpO2 was 87% on room air and 94% 
when receiving oxygen via a mask at 5 L/min.
A chest X-ray showed worsening of the 
bilateral alveolar infiltrate, and a chest CT 
scan showed multifocal ground-glass infiltrate 
(Figures 1 and 2).
A second blood workup revealed the 
following: hemoglobin, 15 g/dL; hematocrit, 
44.5%; leukocytes, 3,300/mm3 (10-79-0-0-8-
1); platelet count, 131,000/mm3; and C-reactive 
protein, 12.36 mg/dL. The results of the arterial 
blood gas analysis were as follows: pH 7.45; 
PaCO2, 35 mmHg; PaO2, 50 mmHg; bicarbonate, 
24 mEq/L; base excess, +0.5 mEq/L; and SaO2, 
87.2%.
Figure 1 - Chest X-ray at admission.
Figure 2 - Chest CT scan at admission.
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respiratory diseases and cardiovascular diseases. 
Of the patients evaluated, 1,538 (7%) died. 
The concomitance of risk factors in the same 
individual results in higher mortality.(4)
The clinical and radiological manifestations 
caused by the influenza virus are not specific. 
The differential diagnosis includes infection with 
other viruses and bacteria, such as respiratory 
syncytial virus, coronavirus, parainfluenza, 
rhinovirus, adenovirus and Mycoplasma sp.(1)
In times of an influenza A pandemic, a 
high level of suspicion should be maintained, 
and, in all severe cases, the diagnosis should 
be confirmed by testing (real-time PCR) of 
nasopharyngeal or oropharyngeal aspirates for 
influenza A.(4) In addition, the use of antiviral 
agents should be initiated, if possible, in the first 
48 h after the onset of symptoms.(5) The early 
use of antiviral agents reduces the severity of the 
disease and of the symptoms.(5)
In general, SARS has an early onset, is 
accompanied by severe hypoxemia and has a 
prolonged course, with extensive tissue damage 
caused by the virus, characterized by necrotizing 
bronchiolitis, neutrophilic infiltrate, diffuse 
alveolar damage and formation of hyaline 
membranes.(6)
The most common radiological 
manifestations of influenza pneumonia consist 
of reticulonodular opacities, with or without 
superimposed areas of consolidation. Less 
commonly, patients with influenza pneumonia 
can present with focal areas of consolidation, 
typically in the lower lobes, without apparent 
reticular or reticulonodular opacities. The 
radiological abnormalities typically resolve in 
approximately three weeks. Consolidations can 
occur due to secondary bacterial pneumonia.(7,8)
On chest CT scans, various patterns are 
possible. However, the ones most commonly 
reported are those showing lobular areas, 
typically bilateral, of ground-glass attenuation. 
Other possible patterns are the presence of focal 
areas of consolidation, centrilobular nodules 
and the tree-in-bud pattern.(9)
The case reported here was a case of SARS 
caused by the influenza A (H1N1) virus and 
presenting a prolonged clinical and radiological 
course. Although there were no characteristics 
of associated bacterial infection, treatment with 
bactericidal antibiotics was initiated early.
presenting with fever > 38°C, cough and 
dyspnea, with or without gastrointestinal 
manifestations or other signs of severity, such as 
tachypnea (RR > 25 breaths/min), hypotension 
or clinical, laboratory and radiological findings 
consistent with bronchopneumonia, as well as 
those resulting in death.(2,3)
Of the 76,639 cases of SARS that had 
been added to the Case Registry Database as 
of November 7, 2009, 24,729 (32.3%) were 
confirmed for infection with the influenza virus 
by laboratory testing, 22,565 (91.0%) of which 
were cases of infection with the influenza A 
(H1N1) virus. There was a slight preponderance 
of cases in females (57%), the median age of the 
confirmed cases was 25 years, and the greatest 
proportion of cases occurred among those in the 
15-49 year age bracket.(4)
In Brazil, the incidence of SARS caused by 
the influenza A (H1N1) virus is 12/100,000 
population, this incidence being of note in 
the following states: Paraná, 109/100,000; 
Santa Catarina, 15/100,000; and São Paulo, 
14/100,000. The nationwide mortality rate is 
0.8/100,000 population.(4)
Of the patients with SARS caused by the 
influenza A (H1N1) virus, 13,316/24,729 (54%) 
had at least one risk factor (such as pregnancy) 
that could lead to complications. Among the 
associated risk factors, in addition to pregnancy, 
are (in ascending order of frequency) obesity, 
hemoglobinopathies, diabetes mellitus, kidney 
disease, age under 2 years, age over 60 years, 
metabolic diseases, immunosuppressive diseases, 
Figure 3 - Chest X-ray at discharge.
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